I

Immuneering Corp
NASDAQ:IMRX

Watchlist Manager
Immuneering Corp
NASDAQ:IMRX
Watchlist
Price: 6.73 USD -1.17% Market Closed
Market Cap: 434.6m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of IMRX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IMRX Intrinsic Value
Not Available
I
Base Case Scenario
Compare IMRX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IMRX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Immuneering Corp

Current Assets 229.1m
Cash & Short-Term Investments 227.6m
Other Current Assets 1.5m
Non-Current Assets 12m
PP&E 4.3m
Intangibles 7m
Other Non-Current Assets 631.3k
Current Liabilities 9.5m
Accounts Payable 1.6m
Accrued Liabilities 7.9m
Other Current Liabilities 80.1k
Non-Current Liabilities 3.5m
Other Non-Current Liabilities 3.5m
Efficiency

Free Cash Flow Analysis
Immuneering Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Immuneering Corp

Revenue
0 USD
Operating Expenses
-64.2m USD
Operating Income
-64.2m USD
Other Expenses
1.7m USD
Net Income
-62.5m USD
Fundamental Scores

IMRX Profitability Score
Profitability Due Diligence

Immuneering Corp's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Sustainable 3Y Average Gross Margin
Declining ROE
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
20/100
Profitability
Score

Immuneering Corp's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

IMRX Solvency Score
Solvency Due Diligence

Immuneering Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Immuneering Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IMRX Price Targets Summary
Immuneering Corp

Wall Street analysts forecast IMRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMRX is 17.17 USD with a low forecast of 11.11 USD and a high forecast of 31.5 USD.

Lowest
Price Target
11.11 USD
65% Upside
Average
Price Target
17.17 USD
155% Upside
Highest
Price Target
31.5 USD
368% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Immuneering Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for IMRX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

IMRX Insider Trading
Buy and sell transactions by insiders